References
- de Brauw L M, van de Velde C JH, Bouwhuis-Hoog-Enverf M L, Zwaveling A. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J Surg Oncol 1987; 34: 81–86
- Hardcastle J D, Armitage N C, Chamberlain J, Amar S S, James P R, Balfour T W. Faecal occult blood screening for colorectal cancer in the general population–results of a controlled trial. Cancer 1986; 58: 397–407
- Turnbull R B, Jr., Kyle K, Watson F R, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967; 166: 42CM27
- Wiggers T, Jeekel J, Arends J W, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. J Surg 1988; 76: 409–415
- Taylor R MR, Parrott N R. Red alert. Br J Surg 1988; 75: 1049–1050
- Voogt P P, van de Velde C JH, Brand A, et al. Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 1987; 59: 836–843
- George C D, Morello P J. Immunologic effects of blood transfusion upon renal transplantations, tumour operations and bacterial infections. J Surg 1986; 152: 329–337
- Persijn G G, Cohen B, Lansbergen Q, van Rood J J. Retrospective and prospective studies on the effect of blood transfusion in renal transplantations in the Netherlands. Transplantation 1979; 28: 396–401
- Lagaay E L, Termijtelen A, Goulmy G, van Rood J J. The presence of 'self MHC class II (HLA-DR) antigens determines whether blood transfusion immunise or suppress [Abstract]. J Cell Biochem 1989; 200, (suppl 13a)
- MRC trial. The evaluation of low-dose preoperative x-ray therapy in the management of operable rectal cancer-results of a randomly controlled trial. Br J Surg 1984; 71: 21–25
- Minton J P, Hoehn J L, Gerber D M, et al. Results of a 400 patient carcinoembryonic antigen second look colorectal cancer study. Cancer 1985; 55: 1284–1290
- August D A, Ottow R T, Sugarbaker P H. Clinical perspective of human colorectal cancer metastasis. Cancer Metast Rev 1984; 3: 303–24
- Finlay I G, McArdle C S. Occult hepatic metastases in colorectal cancer. Br J Surg 1986; 73: 732–735
- van de Velde C JH, de Brauw L M. Attitudes towards detection and management of hepatic metastases in the Western world. Eur J Cancer Clin Oncol 1988; 24: 791–794
- Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103: 278–288
- Taylor I, Machin D, Mulleet M, Trotter G, Cooke T, West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985; 72: 359–363
- Wereldsma J CJ, Bruggink E DM, Meyer W S, Rou-Kema J A, van Putten W LJ. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil-heparin versus urokinase versus control: results of a prospective randomized clinical trial (CRAC I). Cancer 1989, (in press)
- De Brauw L M. Isolated liver perfusion, an experimental modality in the treatment of hepatic metastases. Thesis, University of Leiden, Leiden 1989